Search earnings tickers

VRTX

2024Q1AMC

Vertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-05-06 · Fiscal end 2024-03-31 · Features as of 2024-05-06

← Earnings history

Street

Consensus EPS4.06

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move1.7%

IV front—

P/C full—

P/C front—

Features as of2024-05-06

Run-up

Close—

Ret 5d+1.6%

Ret 10d+0.6%

Ret 20d-0.4%

Ret 30d-3.2%

Print

Actual EPS

4.76Beat

Estimated EPS4.06

Actual revenue

2.7B

Surprise %+17.2%

Beat / missBeat

Beat streak 44

Beat streak 88

Reaction

1-day stock reaction+0.9%

Implied vs actual

Implied 1.7%Actual 1.0%

Gap reaction+1.0%

Day result+1.9%

Next-day upYes

Realized / IV0.56×

Post tape

Post 5d+4.5%

Post 10d+7.7%

Post volume1.6M

Vol ×10d1.54×

Vol ×20d1.53×

Post range5.3%